Sunshine Biopharma, Inc. (SBFM) Down 4.34% in Premarket Trading

Tuesday, April 19, 2022 06:53 AM | InvestorsObserver Analysts

Mentioned in this article

Sunshine Biopharma, Inc. (SBFM) is down Tuesday morning, with the stock losing -4.34% in pre-market trading to 3.31. SBFM's short-term technical score of 13 indicates that the stock has traded less bullishly over the last month than 87% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 136 out of 146 industries, SBFM ranks higher than 25% of stocks. Sunshine Biopharma, Inc. has risen 6.46% over the past month, closing at $2.70 on March 22. During this period of time, the stock fell as low as $2.26 and as high as $9.87.

SBFM has an Overall Score of 26. Find out what this means to you and get the rest of the rankings on SBFM!
Sunshine Biopharma, Inc. has a Long-Term Technical rank of 64. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 36% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 122 by this metric, SBFM ranks better than 78% of stocks.

Important Dates for Investors in SBFM:

-We do not have a set earnings date for Sunshine Biopharma, Inc. at this time. -We do not have a set dividend date for Sunshine Biopharma, Inc. at this time. Click Here To Get The Full Report on Sunshine Biopharma, Inc. (SBFM)

Share this article: